#news #biotech J&J single shot sees 66% efficacy in moderate COVID-19, 85% in severe cases; shares fall

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: J&J single shot sees 66% efficacy in moderate COVID-19, 85% in severe cases; shares fall .J&J single shot sees 66% efficacy in moderate COVID-19, 85% in severe cases; shares fall
badams
Fri, 01/29/2021 – 09:11

from FierceBiotech: Biotech https://ift.tt/3r5cojo